User: Guest  Login
Title:

Phase 1/2a study of the IRAK4 inhibitor CA-4948 as monotherapy or in combination with azacitidine or venetoclax in patients with relapsed/refractory (R/R) acute myeloid leukemia or lyelodysplastic syndrome.

Document type:
Meeting Abstract
Author(s):
Garcia-Manero, Guillermo; Winer, Eric S.; DeAngelo, Daniel J.; Tarantolo, Stefano R.; Sallman, David Andrew; Dugan, James; Groepper, Stefanie; Giagounidis, Aristoteles; Gotze, Katharina S.; Metzeler, Klaus; Li, Chia-Cheng; Zhou, Li; Martinez, Elizabeth; Lane, Maureen E.; Von Roemeling, Reinhard W.; Bohme, Matthias; Kubasch, Anne Sophie; Verma, Amit K.; Platzbecker, Uwe
Journal title abbreviation:
J Clin Oncol
Year:
2022
Journal volume:
40 Suppl S
Journal issue:
16
Print-ISSN:
0732-183X
TUM Institution:
Klinik und Poliklinik für Innere Medizin III, Hämatologie und Onkologie
 BibTeX